You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com | |
Most viewed
- 1. Intrathecal pemetrexed chemotherapy combined with systemic therapy in patients with non-small cell lung cancer and leptomeningeal metastases: a retrospective study
- 2. Mechanistic studies and therapeutic potential of angiopoietin in head and neck tumor angiogenesis
- 3. Clinical Study Shows Modulation of Ki-67 Markers by those taking Avmacol® in Former Smokers at High-risk for Lung Cancer
- 4. The role and research progress of serine metabolism in tumor cells
- 5. Prostate cancer drug now available to more patients with aggressive form of disease
- 6. Test predicts which patients with prostate cancer most likely to develop long-term side effects from radiation therapy
- 7. Editorial: Deciphering the role of signature genes in cancer prognosis and therapy resistance
- 8. Monocyte count combined with GTVnx is an independent prognostic factor in non-metastatic nasopharyngeal carcinoma receiving radiotherapy
- 9. Case Report: FGFR2 inhibitor resistance via PIK3CA and CDKN2A/B in an intrahepatic cholangiocarcinoma patient with FGFR2-SH3GLB1 fusion
- 10. Protocatechualdehyde induced tumor suppressive autophagy through AMPK/ULK1 signaling pathway in gastric cancer
Last updated at 13:23 GMT
Hot News Makers
Health/Pharma Companies
- 18090.04
- 16106.83
- 13185.30
- 12502.25
- 9019.41
- 8903.62
- 8535.47
- 8501.86
- 8485.12
- 8168.62
Drugs, Treatments, Trials
- 29357.13
- 20930.89
- 12363.49
- 12184.09
- 10048.46
- 9475.32
- 8335.26
- 8290.90
- 6609.22
- 6542.96
Last updated at 13:10 GMT
